Tatva Chintan Pharma Chem Limited IPO Details

We are a specialty chemicals manufacturing company engaged in the manufacture of a diverse portfolio of structure directing agents (“SDAs”), phase transfer catalysts (“PTCs”), electrolyte salts for super capacitor batteries and pharmaceutical and agrochemical intermediates and other specialty chemicals (“PASC”). Our Company is the largest and only commercial manufacturer of SDAs for zeolites in India. It also enjoys the second largest position globally. (Source: F&S Report) In addition, our Company is one of the leading global producers of an entire range of PTCs in India and one of the key producers across the globe. 

We continuously strive to improve our processes and infrastructure to help reduce our impact on the environment and have accordingly, undertaken various ‘green’ chemistry processes such as electrolysis. Considering the wide application of our products, we serve customers across various industries, including the automotive, petroleum, pharmaceutical, agro chemicals, paints and coatings, dyes and pigments, personal care and flavour and fragrances industries. Apart from our customers in India, we also export our products to over 25 countries, including the USA, China, Germany, Japan, South Africa, and the UK. We believe that the knowledge and experience of our management team provides us with a significant competitive advantage as we seek to grow our business.
Tatva Chintan Pharma Chem Limited IPO Details
Issue Open 16-07-2021
Issue Close 20-07-2021
Allotment Date 26-07-2021
Unblocked Amount 27-07-2021
Listing Date 28-07-2021
Issue Size
43,35,260 Total Equity Share
- Fresh Issue Equity Share
- OFS Equity Share
Issue Size ₹ 500 Cr
₹ 225 Cr Fresh
₹ 275 Cr OFS
IPO Price Band ₹ 1073-1083
Minimum Share Bid 13
Minimum Investment Amount [₹]  ₹ 14,079
Face Value ₹ 10
Qualified Institutional Buyer [QIB] - %
High Networth Individual [HNI] - %
Retail Individual Investor [RII] - %
Listing On BSE & NSE
Tatva Chintan Pharma Chem Limited IPO Grey Market Premium
Date Offer Price Premium Kostak Subject to Sauda Listing Gain Rating
19-07-2021 1083 740 450 8500 9500 Apply
20-07-2021 1083 760 450 8500 9500 Apply
21-07-2021 1083 810 550 9500 10500 Apply
- - - - - - -
Tatva Chintan Pharma Chem Limited IPO Financial details [in Rs, Cr]
Financial Year Total Asset Total Revenue Total Expenses Profit After Tax
FY-2018 143.716 137.288 118.254 12.28
FY-2019 187.508 206.801 180.157 20.54
FY-2020 248.938 264.622 217.025 37.78
31-12-2021 275.985 195.034 158.577 31.14
Tatva Chintan Pharma Chem Limited IPO Valuation Details
Earnings Per Share [EPS] ₹ 18.81
Price/Earnings [P/E] Ratio 59.29
Return on Net Worth [RoNW] 32.11 %
Net Asset Value [NAV] ₹ 72.05 Per Share
Tatva Chintan Pharma Chem Limited IPO Subscription Details
As on Date QIB NII RII Total
Shared Offered 9,31,966 6,98,975 16,30,941 32,61,882
Tatva Chintan Pharma Chem Limited IPO Grey Market Premium
Check Grey Market Premium :- Click Here
Tatva Chintan Pharma Chem Limited IPO Allotment Status
Check Allotment Status :- Click Here
Live Subscription for Tatva Chintan Pharma Chem Limited IPO
Check Live Subscription in BSE:- Click Here to View
Check Live Subscription in NSE:- Click Here to View
Download Tatva Chintan Pharma Chem Limited IPO DRHP & RHP
Download DRHP:- Click Here to Download
Download RHP:- Click Here to Download
Tatva Chintan Pharma Chem Limited IPO Contact Details
Tatva Chintan Pharma Chem Limited
Plot No. 353, Makarpura GIDC,
Vadodara, Gujarat – 390 010,
Contact Person: Apurva Dubey,
Company Secretary and Compliance Officer;
Telephone: + 91 75748 48533 / +91 75748 48534
E-mail: cs@tatvachintan.com
Corporate Identity Number: U24232GJ1996PLC029894
Registrar of Tatva Chintan Pharma Chem Limited IPO
Link Intime India Private Limited
C-101, 1st Floor, 247 Park
Lal Bahadur Shastri Marg, Vikhroli (West)
Mumbai, Maharashtra - 400 083
Telephone: +91 (22) 4918 6200
E-mail: tatva.ipo@linkintime.co.in
Investor grievance e-mail: tatva.ipo@linkintime.co.in
Contact person: Shanti Gopalkrishnan
SEBI registration number: INR000004058
Lead Managers of Tatva Chintan Pharma Chem Limited IPO
ICICI Securities Limited
ICICI Centre
H.T. Parekh Marg
Churchgate, Mumbai
Maharashtra – 400 020, India
Telephone: +91 22 2288 2460
E-mail: tatvachintan.ipo@icicisecurities.com
Investor grievance e-mail: customercare@icicisecurities.com
Contact person: Vaibhav Saboo / Anurag Bya

JM Financial Limited
7th Floor, Cnergy
Appasaheb Marathe Marg
Prabhadevi, Mumbai 400 025
Maharashtra, India
Telephone: + 91 22 6630 3030
E-mail: tatvachintan.ipo@jmfl.com
Investor grievance e-mail: grievance.ibd@jmfl.com
Website: www.jmfl.com
Contact person: Prachee Dhuri
SEBI registration number: INM000010361
       I request all investors, before applying for any IPO, please check the fundamentals and financial condition of the company and then applying to any IPO.
       www.liveipo.in will not be responsible for any kind of losses. So apply to any IPO at your risk
        We are not buying or selling any IPO forms regarding IPO Grey Market premium. We are only provide only recommendation of any IPO.
       Please do not subscribe to any IPO by just seeing the Grey Market Premium Price. It can change at any time.

0 Response to "Tatva Chintan Pharma Chem Limited IPO Details"

Post a Comment